本集团主要于中国及国际市场从事药品开发、制造及商业化业务。收购所购资产符合本集团透过 《Staccato》平台扩大创新给药技术产品组合(涵盖广泛适应症)的策略，并与本公司的全球拓展策略相 符。收购所购资产将为本公司及其股东带来价值，投资重点包括：(a)《Staccato》One Breath Technology，一项具备广泛治疗潜力的专有平台技术;(b)与本公司现有产品管线互补并产生协同效应;(c) 与全球癫痫治疗领域的生物制药领先公司UCB订立全球特许授权和制造与供应协议，标志着本公司全 球拓展策略的一个重要里程碑。 智通财经APP讯，李氏大药厂(00950)发布公告，于2025年12月8日(交易时段后)，买方Nova Pneuma Incorporated(本公司的间接全资附属公司)、本公司、卖方Alexza Pharmaceuticals, Inc.及卖方母公司Grupo Ferrer International, S.A.，订立资产购买协议，据此，买方同意收购而卖方同意出售与Alexza业务有关的 所购资产，代价为1500万美元。 所购资产包含所有与Alexza业务相关的资产、物业、设备及机械、物料 ...

Group 1 - The company Li's Pharmaceutical (00950) announced an asset purchase agreement with Nova Pneuma Incorporated to acquire assets related to Alexza Pharmaceuticals for a total consideration of $15 million [1] - The acquired assets include all properties, equipment, materials (including work-in-progress), patents, intellectual property, technical know-how, rights, and assigned contracts associated with Alexza's business [1] Group 2 - The acquisition aligns with the company's strategy to expand its innovative drug delivery technology portfolio through the Staccato platform, which covers a wide range of indications [2] - The acquired assets are expected to create value for the company and its shareholders, with a focus on Staccato One Breath Technology, which has broad therapeutic potential [2] - The agreement with UCB, a leading biopharmaceutical company in the global epilepsy treatment field, marks a significant milestone in the company's global expansion strategy [2]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈的內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 對 因 本 公 佈 全部或任何部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責 任。 Lee's Pharmaceutical Holdings Limited 李氏大藥廠控股有限公司 * （於開曼群島註冊成立之有限公司） （股份代號：950） 須予披露交易 收購資產 資產購買協議 董 事 會 欣 然 宣 佈，於 二 零 二 五 年 十 二 月 八 日（交 易 時 段 後），買 方（本 公 司 的 間 接 全 資 附 屬 公 司）、本 公 司、賣 方 及 賣 方 母 公 司 訂 立 資 產 購 買 協 議，據 此，買 方同意收購而賣方同意出售與Alexza業 務 有 關 的 所 購 資 產，代 價 為15,000,000 美 元（相 等 於 約117,000,000港 元）。 上市規則的含義 由於有關資產購買協議及當中擬進行的交易的一個或多個適用百分比率多 於5%但少於25%，故 根 據 上 市 規 則 第 十 四 章，該 交 易 ...

公告发布后，德固特股票于2025年7月14日开市起复牌，复牌当日"20cm"涨停，三个交易日里大涨58.96%。后续过程中，公司11月7日晚间披露了拟终止 重大资产重组的提示性公告，随后公司股价连续下跌，最新价较年内高点跌幅超过40%。 对于终止重大资产重组交易的原因，德固特曾在公告中表示，2025年11月6日，公司收到浩鲸科技发出的《关于交易事项的反馈》。考虑到在有效时间窗 口内难以形成满足各方诉求的方案，公司拟与交易相关方商议终止本次重大资产重组交易。 今年前三季度，德固特业绩相对承压，实现营业收入3.82亿元，同比下降9.29%；实现归母净利润0.72亿元，同比下降26.39%。 （文章来源：证券时报网） 德固特终止筹划重大资产重组事项 12月3日晚间，德固特(300950)公告，公司于2025年12月3日召开第五届董事会第十二次会议，审议通过《关于终止公司发行股份及支付现金购买资产并募 集配套资金暨关联交易的议案》，同意终止本次重大资产重组事项。 德固特在公告中表示，截至本公告披露之日，公司与交易相关方尚未就具体方案最终签署正式实质性协议，各方对拟终止本次交易无需承担任何违约责 任。本次终止重大资产重 ...

Core Viewpoint - The news highlights the recent stability of tin prices above 300,000 yuan per ton and the positive performance of companies in the tin industry, driven by supply constraints and increasing demand from emerging sectors like semiconductors and consumer electronics [1][5][7]. Tin Price and Market Dynamics - Tin futures reached a three-and-a-half-year high, with the main contract peaking at 314,100 yuan per ton, marking a 2.72% increase [5][18]. - The average spot price of tin on December 3 was 309,700 yuan per ton, up 5,630 yuan from the previous trading day, maintaining above 300,000 yuan for five consecutive days [5][18]. - The rise in tin prices is attributed to tight supply from Myanmar and positive macroeconomic expectations, including a high probability of a Federal Reserve interest rate cut [7][20]. Demand Drivers - The demand for tin is primarily driven by the semiconductor industry, which is expected to see a 19.1% increase in global sales in 2024, reaching $627.6 billion [7][20]. - Tin solder demand is projected to grow at a rate of 5% to 7% in 2025, supported by the recovery of the global economy and advancements in new industries [7][20]. Company Performance and Stock Market Reaction - Seven listed companies in the A-share market are involved in the tin industry, with significant investor interest due to rising tin prices [8][21]. - The average stock price increase for tin-related companies this year is 113.08%, with notable gains from companies like Xingye Silver Tin and Shengtun Mining, which saw increases of 226.33% and 160.32%, respectively [8][21]. - In the first three quarters, these companies collectively achieved a net profit of 43.314 billion yuan, a year-on-year increase of 47.47% [9][22]. Individual Company Highlights - Zijin Mining reported a net profit of 37.864 billion yuan in the first three quarters, up 55.45% year-on-year, with significant tin reserves [9][22][23]. - Xiyang Tin achieved a net profit of 1.745 billion yuan, reflecting a 35.99% increase year-on-year, maintaining its position as the largest tin producer globally [10][23]. - Institutional interest is high, with Zijin Mining and Xiyang Tin receiving the most ratings from analysts, indicating strong market confidence [10][23][24].

Core Viewpoint - The company, Degute, announced the termination of its major asset restructuring plan, resulting in a nearly 44% drop in stock price since October 14 [2][8]. Group 1: Termination of Asset Restructuring - On December 3, Degute's board approved the termination of the plan to acquire 100% of Haowei Cloud Computing Technology Co., Ltd. through a combination of share issuance and cash payment [2][5]. - The company aimed to enter the digital transformation sector through this acquisition, which was expected to constitute a significant asset restructuring and related party transaction [5]. - Despite ongoing discussions and negotiations regarding the transaction terms, the parties could not reach an agreement on key aspects such as transaction price and performance commitments [5][6]. Group 2: Financial Performance - For the first three quarters of the year, Degute reported revenue of 382 million yuan, a year-on-year decrease of 9.29%, and a net profit attributable to shareholders of 72.26 million yuan, down 26.39% year-on-year [7]. - As of December 3, Degute's stock closed at 22.8 yuan, reflecting a 43.8% decline from its peak on October 14, with a market capitalization of 3.5 billion yuan [8].

Core Viewpoint - DeguTech announced the termination of its major asset restructuring plan, resulting in a nearly 44% drop in stock price since October 14 [1][5]. Group 1: Termination of Restructuring - On December 3, DeguTech's board approved the termination of the plan to acquire 100% of Haowei Cloud Computing Technology Co., Ltd. through share issuance and cash payment [4][5]. - The company had initially aimed to enter the digital transformation sector through this acquisition to build a differentiated advantage [4][5]. - Despite ongoing discussions, DeguTech and the transaction counterparties could not reach an agreement on key terms such as transaction price and scheme [4][5]. Group 2: Financial Performance - In the first three quarters of the year, DeguTech reported revenue of 382 million yuan, a year-on-year decrease of 9.29%, and a net profit attributable to shareholders of 72.26 million yuan, down 26.39% year-on-year [5]. - As of December 3, DeguTech's stock closed at 22.8 yuan, down 43.8% from its peak of 40.5 yuan on October 14, with a market capitalization of 3.5 billion yuan [5].

Core Viewpoint - The company, Degute (300950), has officially terminated its plan for a major asset restructuring involving the acquisition of Haowei Cloud Computing Technology Co., Ltd. due to failure to reach an agreement on key terms between the parties involved [2][3]. Group 1: Restructuring Process - The restructuring process began in June 2023, with the company planning to acquire 100% of Haowei Technology's shares through a combination of stock issuance and cash payment [2]. - The company’s stock was suspended from trading on June 30, 2023, and resumed trading on July 14, 2023, after the board approved the transaction proposal [3]. - Following the announcement of the restructuring plan, the market had high expectations for the company's transformation, leading to a peak stock price increase of 82% after the resumption of trading [3]. Group 2: Financial Performance and Challenges - Degute faced significant challenges, including intensified industry competition and limited market space, leading to a 26.39% year-on-year decline in net profit for the first three quarters of 2025 [2]. - The financial data from Haowei Technology indicated projected net profits of 202 million yuan and 205 million yuan for 2023 and 2024, respectively, but a seasonal loss of 133 million yuan in the first quarter of 2025, which contributed to valuation disagreements [3]. Group 3: Termination of Restructuring - The company decided to terminate the restructuring to protect the interests of the company and its shareholders, as it was challenging to form a satisfactory plan within the effective time window [4]. - Following the termination, the company signed a release agreement with the transaction parties, stating that no party would bear liability for breach of contract due to the absence of a formal agreement [4]. - The termination of the restructuring is not expected to adversely affect the company's normal business operations, as evidenced by a significant increase of 1447.22% in net cash flow from operating activities for the first three quarters, totaling 60.55 million yuan [4].

12月3日，德固特（300950）发布公告称，公司董事会已审议通过终止发行股份及支付现金购买资产并募集配套资金的议案，这场历时五个月的跨界重组 筹划正式落幕。 公告显示，交易双方未能就核心条款达成一致，是此次重组终止的主要原因。 据了解，德固特此次筹划的重大资产重组始于今年6月。公司原计划通过发行股份及支付现金的方式，收购浩鲸云计算科技股份有限公司（下称"浩鲸科 技"）100%股权，并同步募集配套资金。经初步测算，该交易构成重大资产重组及关联交易，但不会导致公司实际控制人变更，亦不构成重组上市。 对于此次跨界收购，德固特曾在交易预案中明确战略意图。作为深耕节能环保装备制造领域的企业，德固特近年面临行业竞争加剧、细分市场空间受限等 挑战。2025年前三季度，德固特净利润同比下降26.39%。而浩鲸科技作为国际化软件和信息技术服务商，业务覆盖电信软件、云和AI服务等领域，在20 个国家设有子公司，被Gartner评为多个赛道的全球标杆供应商，德固特希望通过此次收购构建第二增长曲线，实现向数智化转型。 回溯重组进程，今年6月30日，德固特股票开市起停牌；7月11日，董事会审议通过交易预案相关议案，股票于7月14日开 ...

呈交日期: 2025年12月2日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00950 | 說明 | | 李氏大藥廠控股有限公司 | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 1,000,000,000 | HKD | | 0.05 | HKD | | 50,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 1,000,000,000 | HKD | | 0.05 | HKD | | 50,000,000 | 本月底法定/註冊股本總額： HKD 50,000,000 致：香港交易及結算所有限公司 公司名稱: 李氏大藥廠控股有限公司 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的 ...